KELIM score: A marker of chemosensitivity in ovarian cancer
Cancer Treatment Reviews · 2026-02 · 143 · 103071
DOI: 10.1016/j.ctrv.2025.103071 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-02. Verfasst von Federica Adele Ambrosino und 17 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Biomarkers, Tumor, CA-125 Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Ovarian cancer is the gynecological cancer with the worst prognosis and the highest mortality rate, primarily because 75% of patients are diagnosed with advanced FIGO stage III-IV disease. About 50% of patients are now treated with neoadjuvant chemotherapy followed by interval debulking surgery. In that context, there is a need for accurate predictors of tumor primary chemosensitivity, as it may impact the feasibility of subsequent interval debulking surgery. The cancer antigen 125 ELIMination rate constant K (KELIM) score, a modeled kinetic parameter, is a potential marker of tumor chemosensitivity in patients with ovarian cancer treated with adjuvant or neoadjuvant chemotherapy before interval debulking surgery. This review aims to provide a comprehensive overview of potential predictive factors for response to platinum therapy, focusing on the KELIM score, a marker increasingly used in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
- Uro-Gynaecological Clinical Experimental Medical Oncology, Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy.
- Laboratory Medicine Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, IRCCS - Fondazione "G. Pascale", Naples, Italy.
- Pathology Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy.
- Interventional Radiology Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy.
- Radiology Division, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy.
Zitieren
APA
Ambrosino, F. A., Pisano, C., Napoli, M. D., Ventriglia, J., Tambaro, R., Rossetti, S., Passarelli, A., Cavalcanti, E., Cecio, R., Fiore, F., Setola, S. V., Troiani, T., Lobianco, L., Perri, E., Lamia, M., Calvanese, G., Pignata, S., & Cecere, S. C. (2026). KELIM score: A marker of chemosensitivity in ovarian cancer. Cancer Treatment Reviews, 143, 103071. https://doi.org/10.1016/j.ctrv.2025.103071
Vancouver
Ambrosino FA, Pisano C, Napoli MD, Ventriglia J, Tambaro R, Rossetti S, et al. KELIM score: A marker of chemosensitivity in ovarian cancer. Cancer Treatment Reviews. 2026;143:103071. doi:10.1016/j.ctrv.2025.103071
BibTeX
@article{Ambrosino2026,
author = {Ambrosino, Federica Adele and Pisano, Carmela and Napoli, Marilena Di and Ventriglia, Jole and Tambaro, Rosa and Rossetti, Sabrina and Passarelli, Anna and Cavalcanti, Ernesta and Cecio, Rossella De and Fiore, Francesco and Setola, Sergio Venanzio and Troiani, Teresa and Lobianco, Lorenzo and Perri, Erica and Lamia, Mariarosaria and Calvanese, Gabriele and Pignata, Sandro and Cecere, Sabrina Chiara},
title = {KELIM score: A marker of chemosensitivity in ovarian cancer},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {143},
pages = {103071},
doi = {10.1016/j.ctrv.2025.103071}
}
EUVIMED